Építés alatt – nem éles oldal
Belépés
Résztvevőt keres itt: Egyesült Államok2. fázis

Post-Operative Dosing of Dexamethasone in Patients With Brain Tumors After a Craniotomy, PODS Trial

A legfontosabb adatok

Hol
Atlanta (Egyesült Államok)A helyszín megnézése
Fázis
2. fázis

Helyszínek itt: Egyesült Államok

  • Emory University Hospital/Winship Cancer InstituteAtlanta, Egyesült ÁllamokContact: Agnes HarutyunyanRésztvevőt keres

Kérdések a vizsgálat csapatának

  1. Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
  2. Megtérítik az utazási költséget?
  3. Megtarthatom a saját orvosomat?
  4. Mi történik, ha ki akarok lépni?

Contact the study team: see the registry record → Contacts and Locations

Oldal nyomtatása az orvosomnak

A vizsgálat adatai

Ki végzi
Emory University
Azonosító
NCT06132685
A regiszteradat frissítve
2026. február 10.
Eredeti leírás
This phase II trial tests the effect of decreasing (tapering) doses of dexamethasone on steroid side effects in patients after surgery to remove (craniotomy) a brain tumor. Steroids are the gold standard post-surgery treatment to reduce swelling (edema) at the surgical site to reduce neurological symptoms. Although, corticosteroids reduce edema, they have side effects including high blood sugar, high blood pressure, and can impair wound healing. Dexamethasone is in a class of medications called corticosteroids. It is used to reduce inflammation and lower the body's immune response. It also works to treat other conditions by reducing swelling and redness. Tapering doses dexamethasone may decrease steroid side effects without increasing the risk of edema in patients with brain tumors after a craniotomy.A teljes eredeti leírásKevesebb

Post-Operative Dosing of Steroids Post Craniotomy for Brain Tumor (PODS)

This phase II trial tests the effect of decreasing (tapering) doses of dexamethasone on steroid side effects in patients after surgery to remove (craniotomy) a brain tumor. Steroids are the gold standard post-surgery treatment to reduce swelling (edema) at the surgical site to reduce neurological symptoms. Although, corticosteroids reduce edema, they have side effects including high blood sugar, high blood pressure, and can impair wound healing. Dexamethasone is in a class of medications called corticosteroids. It is used to reduce inflammation and lower the body's immune response. It also works to treat other conditions by reducing swelling and redness. Tapering doses dexamethasone may decrease steroid side effects without increasing the risk of edema in patients with brain tumors after a craniotomy.

Bevonási feltételek: Patients with radiographic findings consistent with either HGG, LGG, Meningioma, or brain metastasis; Age equal to or above 18.

Kizáró feltételek: Taking immunosuppressive drugs - including but not limited to methotrexate, mycophenolate, rapamycin, tacrolimus, adalimumab, infliximab. Greater than two weeks of recent daily corticosteroid use or the use of corticosteroids equivalent to > 85 mg of dexamethasone in the last month; History of solid organ transplant; History of cerebrovascular accident leading to neurologic deficit; Known hypothalamic-pituitary-adrenal (HPA) axis dysfunction; Tumor causing compression of the sella or pituitary dysfunction; Known immunodeficiency - including but not limited to severe combined immunodeficiency (SCID), common variable immunodeficiency (CVID), lymphocytopenia; Current lymphoma or leukemia; Minors < 18; Pregnant women.

ClinicalTrials.gov NCT06132685